<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="51925">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01873430</url>
  </required_header>
  <id_info>
    <org_study_id>2013-000629-30</org_study_id>
    <nct_id>NCT01873430</nct_id>
  </id_info>
  <brief_title>The Sun Protective Effect of Melatonin</brief_title>
  <official_title>The Sun Protective Effect of Melatonin: a Randomized, Placebo-controlled, Double-blind Study on Healthy Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Herlev Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Herlev Hospital</source>
  <oversight_info>
    <authority>Denmark: Danish Health and Medicines Authority</authority>
    <authority>Denmark: Ethics Committee</authority>
    <authority>Denmark: Danish Dataprotection Agency</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to investigate the sun protective effect of melatonin, when used as
      a cream applied before sun exposure.

      Sun exposure induces erythema as indication of an inflammatory reaction in the skin. It is
      proven that the amount of free radicals in the skin are increased by UV exposure.
      Furthermore, it is known that melatonin is a potent antioxidant. It is hypothesized that
      melatonin can be protective against the UV induced release of free radicals by acting as a
      radical scavenger and thereby protect against UV-induced cellular damage.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study investigates the sun protective effect of melatonin when used as a creme applied
      before sun exposure.

      The study is a randomized, placebo-controlled, double-blinded study conducted on healthy
      volunteers. The volunteers will have 5 squares of 8 cm*8 cm on their backs, which each will
      be randomized to receive one of following: melatonin cream 0,5%; melatonin cream 2,5%;
      melatonin cream 12,5%; placebo cream (vehicle) and no treatment.

      After randomization and received treatment the volunteers will be exposed to strong midday
      sun (UV-index of approximately 9) for 40 minutes.

      The outcomes parameters (degree of erythema and pain sensation) are measured at baseline and
      1,4,8 and 24 hours post exposure.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Actual">August 2013</completion_date>
  <primary_completion_date type="Actual">May 2013</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Reduction of erythema assessed by digital image analysis (Image J) after treatment with melatonin/placebo before sun exposure.</measure>
    <time_frame>Primary outcome is assessed at: baseline and 1,4,8 and 24 hours post exposure</time_frame>
    <safety_issue>No</safety_issue>
    <description>The alpha value measured in a &quot;color space converted&quot; image will represent the degree of erythema</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Testing for primary hyperalgesia in the sun exposed area with Pin-Prick monofilaments. Testing for primary hyperalgesia in the sun-exposed area with Pin-Prick monofilaments.</measure>
    <time_frame>The secondary outcome is assessed at: baseline and 1,4,8 and 24 hours post exposure.</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Visual inspection of erythema using Frosch-Klingman scale.</measure>
    <time_frame>This secondary outcome is assessed at: baseline and 1,4,8 and 24 hours post exposure</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">22</enrollment>
  <condition>Sunburn</condition>
  <arm_group>
    <arm_group_label>Melatonin: Melatonin cream 2,5%</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>One square on the back of each volunteers will be randomized to have the above mentioned dose of melatonin cream applied</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Melatonin: Melatonin cream 0,5%</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>One square on the back of each volunteers will be randomized to have the above mentioned dose of melatonin cream applied.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Melatonin: Melatonin cream 12,5%</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>One square on the back of each volunteers will be randomized to have the above mentioned dose of melatonin cream applied.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo cream</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>One square on the back of each volunteers will be randomized to have placebo cream (vehicle) applied.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No treatment</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>One square on the back of each volunteers will be randomized to receive no treatment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Melatonin</intervention_name>
    <arm_group_label>Melatonin: Melatonin cream 2,5%</arm_group_label>
    <arm_group_label>Melatonin: Melatonin cream 0,5%</arm_group_label>
    <arm_group_label>Melatonin: Melatonin cream 12,5%</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy volunteers of both sexes.

          -  Skin type 1-3 according to Fitzpatrick skin type scale.

          -  No sun exposure on skin area tested in the study 4 weeks prior to the study.

        Exclusion Criteria:

          -  Active skin disease

          -  Participant that do not react to the given sun exposure with a change in a-value &gt;5
             are excluded from the data.

          -  Pregnancy

          -  Previous malignant or pre malignant skin disease.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cecilie Scheuer, Research Scholar</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gastroenheden, Herlev Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Gastroenheden, Herlev Hospital</name>
      <address>
        <city>Herlev</city>
        <zip>2730</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <lastchanged_date>August 28, 2013</lastchanged_date>
  <firstreceived_date>June 6, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Herlev Hospital</investigator_affiliation>
    <investigator_full_name>Cecilie Scheuer</investigator_full_name>
    <investigator_title>Research scholar, medical student</investigator_title>
  </responsible_party>
  <keyword>Melatonin</keyword>
  <keyword>Sunburn</keyword>
  <keyword>Erythema</keyword>
  <keyword>Sunlight</keyword>
  <keyword>Ultraviolet rays</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Sunburn</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Melatonin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
